Highlights
AMEX: PFNX       Pfenex Inc
Last Price Today's Change   Day's Range   Trading Volume
12.30   -0.22 (1.76%)  12.09 - 12.80  373,600

Overview

 
Avg Volume (4 weeks):307,672
4 Weeks Range:10.54 - 13.95
4 Weeks Price Volatility (%):
51.61%
52 Weeks Range:3.40 - 13.95
52 Weeks Price Volatility (%):
84.36%
Average Price Target: 16.00
Price Target Upside/Downside: +3.70

Headlines



No recent Headlines for this stock.


Business Background

Pfenex is a clinical-stage biotechnology company involved in the development of protein production and bioanalytic technology. The biosimilars portfolio include PF582, for the treatment of patients with retinal diseases; PF530, designed to treat patients with multiple sclerosis; and PF708, to treat osteoporosis patients at high risk of fractures. The vaccine portfolio consists of Px563L, a novel anthrax vaccine candidate to meet U.S. government demand, funded by the U.S. Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers